A simple, low-cost colorimetric method for detecting acrylamide in drinking water using hydroxamic acid derivatization and transition metal complexation. Designed as a cheaper alternative to LC-MS and GC-MS, the approach enables ppb-level detection through solution pre-concentration and single-wavelength UV-vis quantification.
This research proposes a colorimetric detection method for acrylamide in drinking water that is significantly simpler and more affordable than current analytical standards such as liquid chromatography-mass spectrometry (LC-MS) or gas chromatography-mass spectrometry (GC-MS). The approach leverages a well-known chemical reaction in which amides are converted to hydroxamic acids using hydroxylamine. Hydroxamic acids are strong ligands for transition metals, and the resulting complexes produce intense colors that can be measured visually or with basic instrumentation. This makes the method accessible to laboratories and field settings that lack expensive mass spectrometry capabilities.
The technology addresses a critical need for routine, cost-effective monitoring of acrylamide, a known contaminant of concern in drinking water. By enabling detection at parts-per-billion (ppb) concentrations through a straightforward pre-concentration step, the method could serve water utilities, environmental testing labs, and regulatory agencies seeking reliable screening tools without the overhead of advanced analytical instrumentation.
Detection principle:
Sensitivity enhancement:
Instrumentation requirements:
This technology is at an early proof-of-concept stage. The underlying chemistry is supported by published literature demonstrating both the derivatization reaction and colorimetric analysis approach, but no independent laboratory validation has been performed yet. The proposed next steps include preparing acrylamide standard solutions across a range of concentrations, performing the derivatization to hydroxamic acid, testing with various transition metals to identify the strongest colorimetric response, and quantifying results using UV-visible spectroscopy. Pre-concentration protocols for dilute solutions will also be evaluated. The simplicity of the proposed chemistry suggests that validation could be completed in a relatively short timeframe, positioning the method for rapid advancement toward practical deployment.
UC Davis is a comprehensive public research university in Northern California, combining a land-grant heritage with an integrated academic health system and a veterinary teaching hospital. Industry engages through co-located clinical and translational facilities in Sacramento, a campus-adjacent research park, pilot-scale food and bioprocessing facilities, and a statewide extension network for field-to-market deployment. Proximity to the Bay Area and California's Central Valley enables rapid collaboration with startups and established enterprises, while corporate relations staff streamline access to faculty, talent, and core labs. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office and venture support programs provide IP management, licensing, and startup formation pathways for industry partnerships.